CVS vs HUM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 12, 2026

CVS

55.2
AI Score
VS
CVS Wins

HUM

53.0
AI Score

Investment Advisor Scores

CVS

55score
Recommendation
HOLD

HUM

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CVS HUM Winner
Revenue 189.89B 39.65B CVS
Net Income 4.89B 1.19B CVS
Net Margin 2.6% 3.0% HUM
Operating Income 8.95B 1.75B CVS
ROE 7.8% 6.4% CVS
ROA 2.2% 2.1% CVS
Total Assets 220.11B 55.28B CVS
Cash 5.19B 4.95B CVS
Debt/Equity 1.10 0.66 HUM
Current Ratio 0.92 1.77 HUM
Free Cash Flow 8.32B 1.13B CVS

Relative Price Performance (Last 90 Days)

CVS 1M: -10.8% · 3M: -0.4% HUM 1M: -5.1% · 3M: +30.7%

Current Technical Phase

CVS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 33.0 · Price: $94.74

HUM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.7% over 20 days), RSI 54

RSI (14): 53.9 · Price: $386.06

Fundamentals Snapshot

Metric CVS HUM
Market Cap
Forward P/E 11.0 22.5
Trailing P/E 25.2 36.4
Revenue (TTM)
Revenue Growth 0.1% 0.3%
Gross Margin 0.1% 0.1%
Operating Margin 0.0% 0.0%
EPS 3.79 10.61
Dividend Yield 0.03% 0.01%

Frequently Asked Questions

Based on our detailed analysis, CVS is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.